MiRus Granted Breakthrough Device Designation for Spine Implant

MiRus received Breakthrough Device Designation from FDA for the EUROPA Posterior Cervical System, based on MiRus' proprietary rhenium alloys, for treatment of the cervical and upper thoracic spine.

EUROPA PCF system is built around a 2.9 mm MoRe rod which is much smaller than current commercial systems. The lower diameter rod allows...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0